ASSURE Wearable ECG vs Viz HCM

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by Kestra Medical Technologies
VS
by Viz.ai

AI Verdict

Tool A, ASSURE Wearable ECG, is designed for continuous heart rate monitoring and data collection via a wearable device, primarily for remote patient management of at-risk cardiac patients. Conversely, Tool B, Viz HCM, is an AI-powered clinical decision support system focused on real-time ECG analysis for detecting suspected Hypertrophic Cardiomyopathy and coordinating care within hospital IT systems. While both utilize ECG data in cardiology, their core functionalities and deployment models cater to distinct aspects of cardiac care, one for ongoing monitoring and the other for acute diagnostic support and workflow optimization.

Choose ASSURE Wearable ECG if…

Choose ASSURE Wearable ECG if your priority is continuous, long-term, and remote heart rate monitoring and data collection for at-risk cardiac patients outside of a hospital setting. This tool is ideal for capturing intermittent cardiac events and providing clinicians with trend data through its wearable device and cloud-based platform, enabling ongoing patient management where passive data collection and alert-based notifications are crucial.

View ASSURE Wearable ECG →

Choose Viz HCM if…

Choose Viz HCM if your primary goal is the rapid, AI-powered detection of suspected Hypertrophic Cardiomyopathy (HCM) from real-time ECGs within a hospital or health system environment. This solution excels at streamlining cardiac care coordination by providing immediate alerts to multidisciplinary teams and automating patient direction to appropriate specialists, significantly reducing diagnosis and treatment times by integrating into existing clinical workflows.

View Viz HCM →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature ASSURE Wearable ECG Viz HCM
Deployment The ASSURE system is intended for use by a patient during their normal daily activities primarily in the home or community setting, but also hospitals, medical clinics, healthcare facilities and transport. Unknown
BAA Available Unknown Yes AI-estimated
FDA Status Cleared AI-estimated Cleared AI-estimated
HIPAA Unknown Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

ASSURE Wearable ECG

Tool A, the ASSURE Wearable ECG, emphasizes patient-centric usability with its 'SensorFit Garment' designed for comfort and a mobile application for continuous monitoring. Its focus on an 'intuitive' and 'mobile' experience for the patient is crucial for adherence to a wearable device. While Tool B focuses on clinician workflow integration, Tool A's direct patient interaction and comfort are key for its specific use case.

Clinical Value

Viz HCM

Tool B, Viz HCM, offers a strong clinical value proposition by using AI for real-time detection of Hypertrophic Cardiomyopathy (HCM) and significantly reducing diagnosis time. Its capabilities are backed by 'extensive real-world evidence and publications,' demonstrating a direct and measurable impact on patient outcomes for a critical condition. While Tool A provides valuable continuous monitoring, Tool B's specific disease detection and expedited care coordination offer a more acute and validated clinical benefit.

Pricing & Value

Viz HCM

Tool B, Viz HCM, provides greater transparency regarding its pricing model, stating it is 'subscription-based' and, importantly, highlighting 'CMS reimbursement available for CPT codes 0764T and 0765T' with a national payment rate. This clear path to reimbursement significantly enhances its financial value for healthcare systems. In contrast, Tool A's pricing is opaque, requiring contact for details.

Enterprise Readiness

Viz HCM

Both tools are HIPAA compliant, have BAA, and FDA cleared. However, Tool B, Viz HCM, explicitly states its deployment as a 'Cloud-based platform, integrated into hospital IT systems (EHR, PACS)' and emphasizes 'seamless integration with existing clinical workflows, EHR, and PACS systems.' This deep integration into core hospital infrastructure makes it more readily adaptable and scalable for enterprise-level adoption in acute care settings.

Innovation

Viz HCM

Tool B, Viz HCM, demonstrates a higher degree of innovation by leveraging AI for real-time, specific disease detection (HCM) from ECGs and then automating care coordination by directing patients to appropriate specialists. This goes beyond data collection to intelligent action and workflow automation. While Tool A offers innovative wearable design and artifact filtering, Tool B's application of AI for direct clinical decision support and care orchestration is more transformative.

Support & Docs

Viz HCM

Viz.ai (Tool B) offers a more comprehensive and transparent support infrastructure, including a 24/7/365 urgent phone support line, a dedicated Help Center/Knowledge Base with troubleshooting and tutorials, and a Trust Center providing extensive documentation on security and compliance. Kestra Medical Technologies (Tool A) provides a helpline and patient/provider resources, but Viz.ai's offerings appear more robust and tailored for enterprise clients.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature ASSURE Wearable ECG Viz HCM
Name ASSURE Wearable ECG Viz HCM
Company Kestra Medical Technologies Viz.ai
Primary Function Non-therapeutic device for continuous heart rate monitoring and data collection, integrated into a digital healthcare platform for at-risk cardiac patients. FDA-cleared AI tool using real-time ECG analysis to detect suspected Hypertrophic Cardiomyopathy (HCM) and coordinate cardiac care, significantly reducing diagnosis time.
Key Detection/Analysis Focus Continuous heart rate monitoring, automatic episode storage, physiologic trend data. AI-powered ECG analysis for Hypertrophic Cardiomyopathy (HCM) detection, real-time disease detection from electrocardiograms.
Core Technology/Algorithm SensorFit Garment with non-adhesive, embedded, and cushioned ECG sensors; ASSURE Detection Algorithm with Quad Channel Processingu2122; Adaptive Patient Intelligenceu2122 for filtering motion artifacts. AI-powered ECG analysis; Clinically validated with extensive real-world evidence and publications.
Care Coordination/Workflow Integration Kestra CareStation remote patient data platform for clinician review, alert-based notifications. Mobile-based alerts and notifications to multidisciplinary care teams, automated direction of patients to appropriate care specialists, streamlines cardiac care coordination and clinical workflows, seamless integration with existing clinical workflows, EHR, and PACS systems.

Videos

Demos, reviews, and walkthroughs featuring ASSURE Wearable ECG and Viz HCM.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

The ASSURE Wearable ECG is a non-therapeutic device for continuous heart rate monitoring and data collection for at-risk cardiac patients, providing physiologic trend data. In contrast, Viz HCM is an AI tool specifically for real-time ECG analysis to detect suspected Hypertrophic Cardiomyopathy (HCM) and coordinate cardiac care, significantly reducing diagnosis time.
The ASSURE Wearable ECG utilizes a wearable device with a SensorFit Garment and an ASSURE Detection Algorithm with Quad Channel Processing, including Adaptive Patient Intelligence for filtering motion artifacts. Viz HCM employs AI-powered ECG analysis to detect suspected Hypertrophic Cardiomyopathy from real-time electrocardiograms.
The ASSURE Wearable ECG integrates via a wearable device, a mobile application, and a cloud-based remote patient data platform called Kestra CareStation for clinician review. Viz HCM is a cloud-based platform designed for seamless integration into hospital IT systems, including EHR and PACS, to streamline cardiac care coordination.
The ASSURE Wearable ECG focuses on continuous heart rate monitoring and general physiologic trend data for at-risk cardiac patients, including automatic episode storage and alert-based notifications. Viz HCM is specifically designed for AI-powered, real-time detection of suspected Hypertrophic Cardiomyopathy (HCM) from ECGs.
The ASSURE Wearable ECG provides alert-based notifications and physiologic trend data via the Kestra CareStation remote patient data platform for clinician review. Viz HCM offers mobile-based alerts and notifications to multidisciplinary care teams, automating the direction of patients to appropriate care specialists and streamlining cardiac care coordination.

Backers

Who funded each tool's parent company.

ASSURE Wearable ECG

AI Tool Finder
AI-powered search. Results may not be comprehensive.